RDY - Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy's for up to $50M

Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today declared that it had agreed to sell its hospital goods to Dr. Reddy’s Laboratories SA, a division of Dr. Reddy’s Laboratories, Ltd. (collectively, “Dr. Reddy’s”) (NYSE: RDY), for a maximum payment of $50 million.

Sean Brynjelsen, CEO of Eton Pharmaceuticals said “The sale of our hospital products allows us to focus our resources on our core rare disease business, which is rapidly growing, and also provides an attractive opportunity to monetize the value we have created with ...